Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Report on assessment of surgical procedures for the treatment of obesity released by EUnetHTA

02 Sep 2021

At the beginning of August 2021, the European Network for Health Technology Assessment, EUnetHTA, released a final report on the surgical procedures for the treatment of obesity. The evaluation was aimed to determine the comparative effectiveness and potential superiority of different bariatric procedures for the treatment of adult obesity in improving outcomes of importance for patients with weight loss, diabetes control, etc.

The following key conclusions are provided:

  • The results suggest little or no difference in the effects of different bariatric surgery procedures on weight loss and diabetes control. However, the results are based mainly on low to very low certainty evidence, with few or even single studies providing data for many of the comparisons;
  • No evidence was found for the effectiveness of the more recent single anastomosis duodenal-ileal bypass with sleeve gastrectomy or single anastomosis sleeve ileal bypass procedures;
  • No study reported on patient satisfaction with the procedure;
  • More high-quality research is needed to determine the relative effect of most obesity surgery procedures, as results for many comparisons are based on data from few studies at high risk of bias;
  • There is a need for studies with longer follow-up in order to assess the long-term effects of obesity surgery;
  • There is a need for standardized definitions, uniform classifications of adverse events, and reporting standards in this field of research to improve the evidence base.

The full details in English can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.